Quantitative brain 18F‐FDG PET/CT analysis in seronegative autoimmune encephalitis
Open Access
- 7 March 2024
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 11 (5) , 1211-1223
Abstract
Objective: Brain Brain F-18-FDG PET/CT is a useful diagnostic in evaluating patients with suspected autoimmune encephalitis (AE). Specific patterns of brain dysmetabolism have been reported in anti-NMDAR and anti-LGI1 AE, and the degree of dysmetabolism may correlate with clinical functional status.(18)FDG-PET/CT abnormalities have not yet been described in seronegative AE. Methods: We conducted a cross-sectional analysis of brain(18)FDG-PET/CT data in people with seronegative AE treated at the Johns Hopkins Hospital. Utilizing NeuroQ (TM) software, the Z-scores of 47 brain regions were calculated relative to healthy controls, then visually and statistically compared for probable and possible AE per clinical consensus diagnostic criteria to previous data from anti-NMDAR and anti-LGI1 cohorts. Results: Eight probable seronegative AE and nine possible seronegative AE were identified. The group only differed in frequency of abnormal brain MRI, which was seen in all of the probable seronegative AE patients. Both seronegative groups had similar overall patterns of brain dysmetabolism. A common pattern of frontal lobe hypometabolism and medial temporal lobe hypermetabolism was observed in patients with probable and possible seronegative AE, as well as anti-NMDAR and anti-LGI1 AE as part of their respective characteristic patterns of dysmetabolism. Four patients had multiple brain(18)FDG-PET/CT scans, with changes in number and severity of abnormal brain regions mirroring clinical status. Conclusions: A(18)FDG-PET/CT pattern of frontal lobe hypometabolism and medial temporal lobe hypermetabolism could represent a common potential biomarker of AE, which along with additional clinical data may facilitate earlier diagnosis and treatment.Keywords
This publication has 25 references indexed in Scilit:
- [18F]FDG brain PET and clinical symptoms in different autoantibodies of autoimmune encephalitis: a systematic reviewNeurological Sciences, 2022
- EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3European Journal of Nuclear Medicine and Molecular Imaging, 2021
- Decrease in the cortex/striatum metabolic ratio on [18F]-FDG PET: a biomarker of autoimmune encephalitisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Different FDG‐PET metabolic patterns of anti‐AMPAR and anti‐NMDAR encephalitis: Case report and literature reviewBrain and Behavior, 2020
- A Metabolic Brain Pattern Associated With Anti-N-Methyl-D-Aspartate Receptor EncephalitisPsychosomatics, 2020
- Autoimmune encephalitis epidemiology and a comparison to infectious encephalitisAnnals of Neurology, 2018
- The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- Striatal hypermetabolism in limbic encephalitisJournal of Neurology, 2011
- Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18Psychiatry Research: Neuroimaging, 2008